AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/127
THE LIMITATIONS OF SIMPLICITY
Authors: LANGE JMA RICHMAN DD
Citation: Jma. Lange et Dd. Richman, THE LIMITATIONS OF SIMPLICITY, Antiviral therapy, 3(1), 1998, pp. 4-6
NAILING DOWN ANOTHER HIV TARGET
Authors: RICHMAN DD
Citation: Dd. Richman, NAILING DOWN ANOTHER HIV TARGET, Nature medicine, 4(11), 1998, pp. 1232-1233
ALKYLTHIOGLYCEROL PRODRUGS OF FOSCARNET - SYNTHESIS, ORAL BIOAVAILABILITY AND STRUCTURE-ACTIVITY STUDIES IN HUMAN CYTOMEGALOVIRUS, HERPES-SIMPLEX VIRUS TYPE 1 AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CELLS
Authors: BEADLE JR KINI GD ALDERN KA GARDNER MF WRIGHT KN RICHMAN DD HOSTETLER KY
Citation: Jr. Beadle et al., ALKYLTHIOGLYCEROL PRODRUGS OF FOSCARNET - SYNTHESIS, ORAL BIOAVAILABILITY AND STRUCTURE-ACTIVITY STUDIES IN HUMAN CYTOMEGALOVIRUS, HERPES-SIMPLEX VIRUS TYPE 1 AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CELLS, Antiviral chemistry & chemotherapy, 9(1), 1998, pp. 33-40
CD40 LIGAND (CD154) STIMULATES MACROPHAGES TO PRODUCE HIV-SUPPRESSIVEBETA-CHEMOKINES
Authors: KORNBLUTH RS KEE K RICHMAN DD
Citation: Rs. Kornbluth et al., CD40 LIGAND (CD154) STIMULATES MACROPHAGES TO PRODUCE HIV-SUPPRESSIVEBETA-CHEMOKINES, The FASEB journal, 12(5), 1998, pp. 5355-5355
CELL-ASSOCIATED VIRAL-RNA EXPRESSION DURING ACUTE INFECTION WITH HIV TYPE-1
Authors: RIGGS NL LITTLE SJ RICHMAN DD GUATELLI JC
Citation: Nl. Riggs et al., CELL-ASSOCIATED VIRAL-RNA EXPRESSION DURING ACUTE INFECTION WITH HIV TYPE-1, AIDS research and human retroviruses, 14(13), 1998, pp. 1141-1149
COMPARATIVE PERFORMANCE OF HIGH-DENSITY OLIGONUCLEOTIDE SEQUENCING AND DIDEOXYNUCLEOTIDE SEQUENCING OF HIV TYPE-1 POL FROM CLINICAL-SAMPLES
Authors: GUNTHARD HF WONG JK IGNACIO CC HAVLIR DV RICHMAN DD
Citation: Hf. Gunthard et al., COMPARATIVE PERFORMANCE OF HIGH-DENSITY OLIGONUCLEOTIDE SEQUENCING AND DIDEOXYNUCLEOTIDE SEQUENCING OF HIV TYPE-1 POL FROM CLINICAL-SAMPLES, AIDS research and human retroviruses, 14(10), 1998, pp. 869-876
SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON MANAGEMENT OF HIV, CMV AND HEPATITIS-VIRUS INFECTIONS
Authors: DEJONG MD BOUCHER CAB DANNER SA GAZZARD B GRIFFITHS PD KATLAMA C LANGE JMA RICHMAN DD VELLA S
Citation: Md. Dejong et al., SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON MANAGEMENT OF HIV, CMV AND HEPATITIS-VIRUS INFECTIONS, Antiviral research, 37(1), 1998, pp. 1-16
SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D JONAS L MEIBOHM A HOLDER D SCHLEIF WA CONDRA JH EMINI EA ISAACS R CHODAKEWITZ JA RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 78-86
ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT
Authors: HIRSCH MS CONWAY B DAQUILA RT JOHNSON VA BRUNVEZINET F CLOTET B DEMETER LM HAMMER SM JACOBSEN DM KURITZKES DR LOVEDAY C MELLORS JW VELLA S RICHMAN DD
Citation: Ms. Hirsch et al., ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT, JAMA, the journal of the American Medical Association, 279(24), 1998, pp. 1984-1991
HOW DRUG-RESISTANCE ARISES
Authors: RICHMAN DD
Citation: Dd. Richman, HOW DRUG-RESISTANCE ARISES, Scientific American, 279(1), 1998, pp. 88-88
MAINTENANCE ANTIRETROVIRAL THERAPIES IN HIV-INFECTED SUBJECTS WITH UNDETECTABLE PLASMA HIV RNA AFTER TRIPLE-DRUG THERAPY
Authors: HAVLIR DV MARSCHNER IC HIRSCH MS COLLIER AC TEBAS P BASSETT RL IOANNIDIS JPA HOLOHAN MK LEAVITT R BOONE G RICHMAN DD
Citation: Dv. Havlir et al., MAINTENANCE ANTIRETROVIRAL THERAPIES IN HIV-INFECTED SUBJECTS WITH UNDETECTABLE PLASMA HIV RNA AFTER TRIPLE-DRUG THERAPY, The New England journal of medicine, 339(18), 1998, pp. 1261-1268
CD40 LIGAND (CD154) STIMULATION OF MACROPHAGES TO PRODUCE HIV-1-SUPPRESSIVE BETA-CHEMOKINES
Authors: KORNBLUTH RS KEE K RICHMAN DD
Citation: Rs. Kornbluth et al., CD40 LIGAND (CD154) STIMULATION OF MACROPHAGES TO PRODUCE HIV-1-SUPPRESSIVE BETA-CHEMOKINES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(9), 1998, pp. 5205-5210
HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION AND GENOTYPIC RESISTANCE IN BLOOD AND LYMPH-NODES AFTER A YEAR OF POTENT ANTIRETROVIRAL THERAPY
Authors: GUNTHARD HF WONG JK IGNACIO CC GUATELLI JC RIGGS NL HAVLIR DV RICHMAN DD
Citation: Hf. Gunthard et al., HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION AND GENOTYPIC RESISTANCE IN BLOOD AND LYMPH-NODES AFTER A YEAR OF POTENT ANTIRETROVIRAL THERAPY, Journal of virology, 72(3), 1998, pp. 2422-2428
MOLECULAR AND CELLULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS-INDUCED APOPTOSIS IN LYMPHOBLASTOID T-CELL-LINE-EXPRESSING WILD-TYPE AND MUTATED CD4 RECEPTORS
Authors: MOUTOUH L ESTAQUIER J RICHMAN DD CORBEIL J
Citation: L. Moutouh et al., MOLECULAR AND CELLULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS-INDUCED APOPTOSIS IN LYMPHOBLASTOID T-CELL-LINE-EXPRESSING WILD-TYPE AND MUTATED CD4 RECEPTORS, Journal of virology, 72(10), 1998, pp. 8061-8072
HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN AIDS PATIENTS WITH MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA - A CASE-CONTROL STUDY
Authors: HAVLIR DV HAUBRICH R HWANG J DUNNE MW CURRIER J FORTHAL D TORRIANI F RICHMAN DD MCCUTCHAN JA
Citation: Dv. Havlir et al., HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN AIDS PATIENTS WITH MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA - A CASE-CONTROL STUDY, The Journal of infectious diseases, 177(3), 1998, pp. 595-599
USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY
Authors: MARSCHNER IC COLLIER AC COOMBS RW DAQUILA RT DEGRUTTOLA V FISCHL MA HAMMER SM HUGHES MD JOHNSON VA KATZENSTEIN DA RICHMAN DD SMEATON LM SPECTOR SA SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
IMMUNOSTIMULATORY DNA-SEQUENCES FUNCTION AS T-HELPER-1-PROMOTING ADJUVANTS
Authors: ROMAN M MARTINOROZCO E GOODMAN S NGUYEN MD SATO Y RONAGHY A KORNBLUTH RS RICHMAN DD CARSON DA RAZ E
Citation: M. Roman et al., IMMUNOSTIMULATORY DNA-SEQUENCES FUNCTION AS T-HELPER-1-PROMOTING ADJUVANTS, Nature medicine, 3(8), 1997, pp. 849-854
HIV-1 - GAMBLING ON THE EVOLUTION OF DRUG-RESISTANCE
Authors: BROWN AJL RICHMAN DD
Citation: Ajl. Brown et Dd. Richman, HIV-1 - GAMBLING ON THE EVOLUTION OF DRUG-RESISTANCE, Nature medicine, 3(3), 1997, pp. 268-271
SAFETY AND ANTIVIRAL ACTIVITY OF COMBINATION THERAPY WITH ZIDOVUDINE,ZALCITABINE, AND 2 DOSES OF INTERFERON-ALPHA(2A) IN PATIENTS WITH HIV- AIDS CLINICAL-TRIALS GROUP-STUDY-197
Authors: FISCHL MA RICHMAN DD SAAG M MENG TC SQUIRES KE HOLDENWILTSE J MEEHAN PM
Citation: Ma. Fischl et al., SAFETY AND ANTIVIRAL ACTIVITY OF COMBINATION THERAPY WITH ZIDOVUDINE,ZALCITABINE, AND 2 DOSES OF INTERFERON-ALPHA(2A) IN PATIENTS WITH HIV- AIDS CLINICAL-TRIALS GROUP-STUDY-197, Journal of acquired immune deficiency syndromes and human retrovirology, 16(4), 1997, pp. 247-253
PHASE I II STUDY OF THE TOXICITY, PHARMACOKINETICS, AND ACTIVITY OF THE HIV PROTEASE INHIBITOR SC-52151/
Authors: FISCHL MA RICHMAN DD FLEXNER C PARA MF HAUBRICH R KARIM A YERAMIAN P HOLDENWILTSE J MEEHAN PM
Citation: Ma. Fischl et al., PHASE I II STUDY OF THE TOXICITY, PHARMACOKINETICS, AND ACTIVITY OF THE HIV PROTEASE INHIBITOR SC-52151/, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 28-34
THE ROLE OF VIRAL DYNAMICS IN THE PATHOGENESIS OF HIV DISEASE AND IMPLICATIONS FOR ANTIVIRAL THERAPY
Authors: HAVLIR DV RICHMAN DD
Citation: Dv. Havlir et Dd. Richman, THE ROLE OF VIRAL DYNAMICS IN THE PATHOGENESIS OF HIV DISEASE AND IMPLICATIONS FOR ANTIVIRAL THERAPY, Perspectives in mathematical logic, 18(3), 1997, pp. 267-283
ALKOXY PROPANE PRODRUGS OF FOSCARNET - EFFECT OF ALKYL CHAIN-LENGTH ON IN-VITRO ANTIVIRAL ACTIVITY IN CELLS INFECTED WITH HIV-1, HSV-1 AND HCMV
Authors: KINI GD BEADLE JR XIE H ALDERN KA RICHMAN DD HOSTETLER KY
Citation: Gd. Kini et al., ALKOXY PROPANE PRODRUGS OF FOSCARNET - EFFECT OF ALKYL CHAIN-LENGTH ON IN-VITRO ANTIVIRAL ACTIVITY IN CELLS INFECTED WITH HIV-1, HSV-1 AND HCMV, Antiviral research, 36(1), 1997, pp. 43-53
SUMMARY OF THE 2ND INTERNATIONAL CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY AND IMPLICATIONS FOR FUTURE THERAPIES
Authors: DEJONG MD BOUCHER CAB COOPER DA GALASSO GJ GAZZARD B LANGE JMA MONTANER JS RICHMAN DD THOMAS HC
Citation: Md. Dejong et al., SUMMARY OF THE 2ND INTERNATIONAL CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY AND IMPLICATIONS FOR FUTURE THERAPIES, Antiviral research, 35(2), 1997, pp. 65-82
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 277(24), 1997, pp. 1962-1969
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>